Biosurgery Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Biosurgery refers to the use of biological materials and substances to achieve hemostasis, seal tissues, and promote tissue regeneration during surgical procedures. The global market encompasses product categories such as bone-graft substitutes, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and soft-tissue attachments. Valued at approximately $16.88 billion in 2025, the sector is positioned for steady expansion as surgical volumes increase across orthopedic, cardiovascular, general, and reconstructive procedures globally.

• •Market valued at $16.88 billion in 2025, with projections reaching approximately $21.59 billion by 2030
• •Key product categories include bone-graft substitutes, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and soft-tissue attachments
• •Applied across orthopedic, cardiovascular, general surgery, and reconstructive procedures

The rising global incidence of chronic diseases, trauma cases, and age-related musculoskeletal disorders is increasing demand for surgical interventions, directly fueling biosurgery product consumption. An aging worldwide population contributes to higher rates of orthopedic and cardiovascular procedures, both of which rely heavily on biosurgical products. Additionally, the growing adoption of minimally invasive surgical techniques, which often require specialized sealing and hemostasis products, continues to expand the addressable market.

• •Rising prevalence of chronic diseases and trauma cases driving increased surgical volumes globally
• •Aging population contributing to higher rates of orthopedic and cardiovascular procedures requiring biosurgical products
• •Growing preference for minimally invasive surgical techniques increasing demand for specialized sealing and hemostasis products

The market is segmented by product type, application, end-user, and geography, with bone-graft substitutes and hemostatic agents representing the largest product segments by revenue. North America holds the largest regional market share, supported by advanced healthcare infrastructure, high surgical volumes, and favorable reimbursement policies. The Asia-Pacific region is expected to witness the fastest growth, driven by improving healthcare access, rising medical tourism, and increasing healthcare expenditure in countries such as China and India.

• •Product segmentation includes bone-graft substitutes, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and soft-tissue attachments
• •North America leads in market share due to advanced healthcare infrastructure and high surgical volumes
• •Asia-Pacific is the fastest-growing region, fueled by improving healthcare access and rising expenditure in China, India, and neighboring markets

What are the recent trends and outlook?

Ongoing product innovation, including the development of synthetic and recombinant biological materials, is expected to drive incremental market growth and address limitations associated with traditional biological products. The rising adoption of regenerative medicine and tissue engineering approaches may introduce new categories of biosurgical solutions over the forecast horizon. Overall, the market is well-positioned for sustained growth through 2030, supported by demographic trends, surgical volume expansion, and continued technological advancement.

• •Development of synthetic and recombinant biosurgical materials is expanding treatment options and product performance
• •Regenerative medicine and tissue engineering are emerging as complementary forces in the biosurgery space
• •Market projected to maintain a compound annual growth rate of approximately 6.35% through 2030, reaching around $21.59 billion